share_log

Invivyd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Maverick Capital, Ltd.(9.9%),Maverick Capital Management, LLC(9.9%), etc.

Invivyd | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Maverick Capital, Ltd.(9.9%),Maverick Capital Management, LLC(9.9%), etc.

Invivyd | SC 13G/A:超过5%持股股东披露文件(修正)-Maverick Capital, Ltd.(9.9%),Maverick Capital Management, LLC(9.9%)等
美股SEC公告 ·  11/15 05:37

Moomoo AI 已提取核心信息

On September 30, 2024, Invivyd, Inc., a company specializing in biotechnology with its principal executive offices located in Waltham, MA, was the subject of a Schedule 13G/A filing with the United States Securities and Exchange Commission. The filing was made by Maverick Capital, Ltd., Maverick Capital Management, LLC, and Lee S. Ainslie III, indicating a shared voting and dispositive power over 11,765,787 shares of Invivyd's common stock, which represents 9.9% of the class. The shares are held for the accounts of Maverick Capital, Ltd.'s clients. Maverick Capital, Ltd. is an investment adviser with beneficial ownership of the shares through the investment discretion it exercises over its clients' accounts. Maverick Capital Management, LLC is the General Partner of Maverick Capital, Ltd., and Mr...Show More
On September 30, 2024, Invivyd, Inc., a company specializing in biotechnology with its principal executive offices located in Waltham, MA, was the subject of a Schedule 13G/A filing with the United States Securities and Exchange Commission. The filing was made by Maverick Capital, Ltd., Maverick Capital Management, LLC, and Lee S. Ainslie III, indicating a shared voting and dispositive power over 11,765,787 shares of Invivyd's common stock, which represents 9.9% of the class. The shares are held for the accounts of Maverick Capital, Ltd.'s clients. Maverick Capital, Ltd. is an investment adviser with beneficial ownership of the shares through the investment discretion it exercises over its clients' accounts. Maverick Capital Management, LLC is the General Partner of Maverick Capital, Ltd., and Mr. Ainslie is the manager of Maverick Capital Management, LLC. The ownership reported is based on 119,442,635 outstanding shares as disclosed in Invivyd's Quarterly Report filed on August 14, 2024. The filing asserts that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Invivyd, Inc.
在2024年9月30日,Invivyd公司是一家专注于生物技术的公司,其主要执行办公室位于马萨诸塞州沃尔瑟姆,向美国证券交易委员会提交了Schedule 13G/A档案。该档案由Maverick Capital, Ltd.、Maverick Capital Management, LLC和Lee S. Ainslie III提交,显示对11,765,787股Invivyd普通股拥有共同投票权和处置权,这占该类别的9.9%。这些股份是为Maverick Capital, Ltd.客户的账户持有的。Maverick Capital, Ltd.是一家投资顾问,通过对其客户账户的投资自由裁量权获得这些...展开全部
在2024年9月30日,Invivyd公司是一家专注于生物技术的公司,其主要执行办公室位于马萨诸塞州沃尔瑟姆,向美国证券交易委员会提交了Schedule 13G/A档案。该档案由Maverick Capital, Ltd.、Maverick Capital Management, LLC和Lee S. Ainslie III提交,显示对11,765,787股Invivyd普通股拥有共同投票权和处置权,这占该类别的9.9%。这些股份是为Maverick Capital, Ltd.客户的账户持有的。Maverick Capital, Ltd.是一家投资顾问,通过对其客户账户的投资自由裁量权获得这些股份的实益所有权。Maverick Capital Management, LLC是Maverick Capital, Ltd.的普通合伙人,Ainslie先生是Maverick Capital Management, LLC的经理。报告的所有权基于在2024年8月14日提交的Invivyd季度报告中披露的119,442,635股流通股。该档案声明这些股份是在正常的业务过程中获得并持有的,并不是为了改变或影响Invivyd, Inc.的控制权。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息